Wantai Kechuang

Beijing Wantai Kechuang Biotechnology is a specialized subsidiary of Beijing Wantai Biological Pharmacy Enterprise, focusing on the research, development, and production of in vitro diagnostic (IVD) reagents. The company is a major provider of diagnostic kits for infectious diseases, including hepatitis, HIV, and syphilis, serving blood banks and clinical laboratories worldwide. Its product portfolio leverages enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA) technologies to ensure high sensitivity and specificity. Wantai Kechuang plays a critical role in the parent company's integrated approach to public health, which spans from diagnostics to vaccine development. The company operates from a large-scale, GMP-certified facility in Beijing, ensuring rigorous quality control for its extensive portfolio of diagnostic kits. As part of the broader Wantai group, it benefits from significant R&D collaborations, most notably with Xiamen University.